Our latest
News

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update

Mauna Kea Technologies Announces its 2025 Financial Calendar

Raising Pancreatic Cancer Awareness Through Patient Voices

Mauna Kea Technologies Celebrates Over 700 Procedures Performed in 18 Months at IECED-OMNI Hospital in Ecuador

Mauna Kea Technologies Announces Review of Strategic Alternatives

Mauna Kea Technologies Provides an Update on Its Recent Developments

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio
